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https://doi.org/10.1186/s12884-019-2365-9RESEARCH ARTICLE Open AccessMaternal plasma levels of oxytocin during
physiological childbirth – a systematic
review with implications for uterine
contractions and central actions of oxytocin
Kerstin Uvnäs-Moberg1, Anette Ekström-Bergström2,3*, Marie Berg4,5, Sarah Buckley6, Zada Pajalic7,
Eleni Hadjigeorgiou8, Alicja Kotłowska9, Luise Lengler10, Bogumila Kielbratowska11, Fatima Leon-Larios12,
Claudia Meier Magistretti13, Soo Downe14, Bengt Lindström15 and Anna Dencker4,5Abstract
Background: Oxytocin is a key hormone in childbirth, and synthetic oxytocin is widely administered to induce or
speed labour. Due to lack of synthetized knowledge, we conducted a systematic review of maternal plasma levels
of oxytocin during physiological childbirth, and in response to infusions of synthetic oxytocin, if reported in the
included studies.
Methods: An a priori protocol was designed and a systematic search was conducted in PubMed, CINAHL, and
PsycINFO in October 2015. Search hits were screened on title and abstract after duplicates were removed (n =
4039), 69 articles were examined in full-text and 20 papers met inclusion criteria. As the articles differed in design
and methodology used for analysis of oxytocin levels, a narrative synthesis was created and the material was
categorised according to effects.
Results: Basal levels of oxytocin increased 3–4-fold during pregnancy. Pulses of oxytocin occurred with increasing
frequency, duration, and amplitude, from late pregnancy through labour, reaching a maximum of 3 pulses/10 min
towards the end of labour. There was a maximal 3- to 4-fold rise in oxytocin at birth. Oxytocin pulses also occurred in
the third stage of labour associated with placental expulsion. Oxytocin peaks during labour did not correlate in time
with individual uterine contractions, suggesting additional mechanisms in the control of contractions. Oxytocin levels
were also raised in the cerebrospinal fluid during labour, indicating that oxytocin is released into the brain, as well as
into the circulation. Oxytocin released into the brain induces beneficial adaptive effects during birth and postpartum.
Oxytocin levels following infusion of synthetic oxytocin up to 10mU/min were similar to oxytocin levels in
physiological labour. Oxytocin levels doubled in response to doubling of the rate of infusion of synthetic oxytocin.
Conclusions: Plasma oxytocin levels increase gradually during pregnancy, and during the first and second stages of
labour, with increasing size and frequency of pulses of oxytocin. A large pulse of oxytocin occurs with birth. Oxytocin in
the circulation stimulates uterine contractions and oxytocin released within the brain influences maternal physiology
and behaviour during birth. Oxytocin given as an infusion does not cross into the mother’s brain because of the blood
brain barrier and does not influence brain function in the same way as oxytocin during normal labour does.
Keywords: Oxytocin, Plasma levels, Pregnancy, Physiological labour, Birth, Uterine contractions, Central effects,
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Oxytocin is an important hormone in labour and birth,
when it helps the labouring woman’s uterus to contract
and birth her baby. We searched for all the studies that
measured blood levels of oxytocin in women during nor-
mal (physiological) labour and birth.
We found that blood oxytocin levels gradually rise in
pregnancy and become even higher during labour, when
pulses of oxytocin become progressively bigger and
more frequent. Oxytocin contracts the uterus and pro-
motes the progress of labour. A large oxytocin pulse oc-
curs with the birth, and pulses continue afterwards,
which help the new mother to birth the placenta, pre-
vent bleeding, and warm her chest for skin-to-skin con-
tact with her baby.
During labour, oxytocin is released into both the blood
and brain, with high oxytocin levels in the brain fluid
(cerebrospinal fluid, CSF). Oxytocin has many positive
effects in the mother’s brain during labour, and prepares
her for motherhood. Oxytocin reduces anxiety, stress
and pain in labour and switches on brain pleasure and
reward centres, making the new mother relaxed, and
happy as she meets her baby for the first time.
Several studies measured oxytocin levels when infu-
sion of synthetic oxytocin was used for induction or aug-
mentation of labour. These studies found that low doses
of synthetic oxytocin produced similar oxytocin levels as
physiological labour whereas high doses gave abnormally
high oxytocin levels, in proportion to dosage. Labour in-
duced by synthetic oxytocin differs in some way from
normal, physiological labour. It may, especially at high
dosages cause more, longer and more painful contrac-
tions, when compared to normal labour. Oxytocin given
as an infusion does not cross into the mother’s brain be-
cause of the blood brain barrier and does not influence
brain function in the same way as normal labour does.
Background
The peptide hormone oxytocin was discovered in 1906 by
Sir Henry Dale, who found that a pituitary extract stimu-
lated uterine contractility in cats [1]. The chemical struc-
ture of oxytocin was elucidated in the 1950s by Vincent
du Vigneaud and oxytocin was synthesized soon after [2].
It is well known that oxytocin plays a pivotal role dur-
ing human labour and birth.
Oxytocin is produced in neurons that originate in the
paraventricular (PVN) and supraoptic (SON) nuclei of
the hypothalamus, and is transported to the posterior
pituitary. During labour, oxytocin is released in pulses
from the pituitary into the circulation to induce uterine
contractions [3].
Research interest in oxytocin has increased dramatic-
ally in recent years, as oxytocin has been found to have
many positive physiological and psychological effects [4].This is due to the fact that oxytocin is released within
the brain. Oxytocinergic nerves originating in the PVN
project to many important regulatory areas, where
oxytocin is released to act as a neuromodulator, with
widespread central effects [5]. For example, oxytocin
enhances mood and wellbeing; promotes friendly social
interactions; reduces anxiety and pain; and lowers
physiological and psychological stress, among other
benefits [6]. In addition, it reduces sympathetic nervous
system activity (“fight or flight”), and increases parasym-
pathetic nervous system activity (“relaxation and growth”
and “calm and connection”) [4]. Given this information
on oxytocin, and its established role in maternal behav-
iours in all mammals [7], it is important to consider the
possible effects of oxytocin released in the brain during
childbirth.
In addition, infusions of synthetic oxytocin are widely
used in maternity care to induce or augment labour, and
are also recommended to prevent or treat postpartum
bleeding [8]. Because of the widespread and increased
use of synthetic oxytocin, it is critical to understand the
possible impacts on endogenous oxytocin, and on
oxytocin-mediated effects in mothers and babies [9, 10].
As part of a collaborative European project initiated
within the European COST program IS1405, we aim at
performing several systematic reviews summarizing exist-
ing data on plasma levels and effects of oxytocin in
mothers, during and after physiological childbirth, includ-
ing longer-term effects on breastfeeding, attachment, and
mental health, and in women with and without medical
interventions. Recent information on the beneficial central
effects of oxytocin must be incorporated into the present
knowledge about the role of oxytocin during physiological
labour.
Previous studies that measured oxytocin levels during
birth were mainly published in the 1970s to 90s. Most of
these older studies are of high quality and provide an ac-
curate assessment of oxytocin levels, and would be diffi-
cult to perform today because of technical, practical and
ethical reasons. It is of importance to bring back this for-
gotten but highly relevant knowledge to healthcare profes-
sionals of today involved in labour and birth. In addition,
there are many misunderstandings regarding the effects of
endogenous oxytocin and exogenous synthetic oxytocin
during childbirth that could be resolved by access to this
knowledge, with benefits for clinical care.
The specific aim of this systematic review is to
summarize existing data on plasma levels of oxytocin
during normal physiological birth. In addition, data from
the reviewed studies on plasma levels of oxytocin after
infusions of synthetic oxytocin will be included. This will
allow comparison between oxytocin levels observed dur-
ing physiological birth and in birth induced or aug-
mented with synthetic oxytocin. We will also discuss the
Fig. 1 Flow diagram of study selection
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during physiological birth.
Methods
A systematic review was carried out according to the
PRISMA statement [11]. An a priori protocol was de-
signed, outlining the aim and procedure for the review.
Inclusion criteria were studies presenting blood/plasma
oxytocin levels in women having had a normal preg-
nancy without medical complications, a physiological
birth, and who had given birth to a healthy baby at term.
Included were peer-reviewed original research studies
comprising at least one measure of plasma oxytocin
levels in women during a physiological labour, and
which were written in either English, French or German
as these were the languages available to the review team.
Search strategy
A comprehensive and systematic search was done in the
following databases: PubMed, CINAHL and PsycINFO
in October 2015, to identify studies or existing system-
atic reviews. We also hand-searched the reference lists
of all eligible publications for references to other pos-
sibly relevant studies. The search string is available in
the Additional file 1.
A total of 4039 publications were found after removal of
duplicates. Assessment of titles and abstracts were divided
in six groups of authors (KUM & AEB; AK& BK; MB &
LL; EH & CMM; FLL & ZP; AD & SD) and assessed inde-
pendently by the authors in pairs. The assessment was
based on the inclusion criteria, i.e. women without med-
ical complications during pregnancy or labour. In case of
disagreement a third reviewer (KUM) was involved. This
process ended in exclusion of 3973 papers. The full text of
the remaining papers (n = 66) was read by a team of two
researchers (KUM and AEB). Three further studies were
added from reference lists giving 69 papers which were
screened for eligibility. Of these studies 49 were excluded
because they did not fulfil the inclusion criteria. This
process led to a final number of 20 publications to be in-
cluded for data extraction. For overview of study selection
see the flow diagram in Fig. 1.
Data extraction and analysis
A combined analysis of all data was not possible because
the studies differed substantially as to the type of bio-
chemical analysis used to determine oxytocin levels as to
when during labour, as well as to the timing and the fre-
quency of blood sampling (single samples, repeated sam-
ples with different time intervals including months,
weeks, hours, minutes or seconds). We therefore created
a narrative synthesis for each article. From these narra-
tive results, oxytocin levels during labour were extracted
and then summarized to allow characterization ofoxytocin levels during the different time periods of birth,
and also comparison between groups.
Some of the included studies also contained information
about plasma levels of oxytocin during basal conditions
(non-pregnant women) and during pregnancy. These data
were included to allow comparison between oxytocin levels
in these situations and plasma levels of oxytocin during
birth. Information about oxytocin levels in cerebrospinal
fluid (CSF) during pregnancy and birth was also included.
Data on oxytocin levels following bolus injections or infu-
sions of synthetic oxytocin described in the included studies
are also presented. Finally, data on the association between
uterine contractions and plasma levels of oxytocin were in-
cluded. In some studies, oxytocin levels were measured
both before and after medical interventions. In all except
one of the included studies, radioimmunoassay (RIA) was
used to determine oxytocin levels [12].
The levels of oxytocin in the 20 selected papers were
presented in different measures/units, e.g. μU/mL, pg/mL
or pmol/L (pM). In order to facilitate interpretation of the
results, Table 1 shows conversion between international
units (IU), weight units (g) and molar units (M). All sam-
ples were from peripheral veins, except one study that
simultaneously also collected blood from the jugular vein.
Results
As described, 20 articles that measured oxytocin levels dur-
ing labour and birth met the criteria for inclusion [13–32].
The studies were published between 1965 and 2001. In
addition to measurement of oxytocin levels in labour, oxy-
tocin levels were also measured during pregnancy in 10 of
the 20 included studies. Some studies also included mea-
sures of oxytocin levels in non-pregnant women. Charac-
teristics of the included articles are reported in Table 2.
Table 1 Conversion of oxytocin levels between units
Conversion of different size units:
1 Unit (IU) = 1000 milliunits (mU) = 1000,000 microunits (μU)
1 g (g) = 1000 mg (mg) = 1000,000 micrograms (μg) = 1000,000,000
nanograms (ng) = 1000,000,000,000 picograms (pg)
1 Mol/L = 1 Molar (M) = 1000 milliMolar (mM) = 1000,000 microMolar
(μM) = 1000,000,000 nanoMolar (nM) = 1000,000,000,000 picoMolar
(pM)
Conversion of units (U) to weight units:
1 IU = 1.67 μg, 1 μg = 0.60 U
1mU = 1.67 ng, 1 ng = 0.60 mU
1 μU = 1.67 pg, 1 pg = 0.60 μU
Conversion of weight/volume of oxytocin to Molarity
(molecular weight of oxytocin equal to 1007 g/mol):
1 g/mL = 1mol/L = 1 M
1mg/mL = 1mmol/L = 1mM
1 μg /mL = 1 μmol/L = 1 μM
1 ng/mL = 1 nmol/L = 1 nM
1 pg/mL = 1 pmol/L = 1pM
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in Table 3. The results obtained after extraction of data
from the individual articles were summarized into categor-
ies, which are presented as follows; “Summary of oxytocin
levels during labour and birth” (Table 4); “Summary of oxy-
tocin levels during pregnancy and in non-pregnant women”
(Table 5) and “Summary of the occurrence of uterine con-
tractions in relation to plasma levels of oxytocin during
labour without and with synthetic oxytocin” (Table 6).
Four schematic figures were created which describe the
change of oxytocin levels over time (Figs. 2, 3a, b, and 4).
The data used for the figures have been taken from the in-
cluded studies, as indicated in the text legends of the fig-
ures, and have been transformed and simplified for clarity.
Figures show oxytocin levels during pregnancy and labour
(Fig. 2), the pattern of oxytocin levels during spontaneous
labour versus induction of labour with infusion of syn-
thetic oxytocin (Fig. 3a and b), and the very short-lasting
character of oxytocin pulses (Fig. 4).
Extraction of data from the included articles
Data from the included articles has been reported in
Tables 1, 2, 3, 4, 5, 6 and Figs. 2, 3a, b, and 4, as
described above.
Coch et al. 1965 [13]
Serial blood samples were collected from 18 women dur-
ing physiological birth. “Oxytocin equivalent activity” was
demonstrated in samples collected from both the jugular
vein (levels ranged between 300 and 900 μU/mL) and a
peripheral vein (levels up to 100 μU/mL). The oxytocin
equivalent activity increased as labour progressed andreached maximum levels during the second stage of
labour, when oxytocin equivalent activity in the jugular
vein was up to 8- to 9-fold higher than that in peripheral
plasma. After birth, jugular vein oxytocin equivalent activ-
ity decreased to levels in peripheral venous blood. The
high levels of oxytocin equivalent activity in the jugular
vein relative to those in a peripheral vein indicate that
oxytocin is released from a central source (the pituitary)
during the second phase of labour.
Kumaresan et al. 1974 [14]
Multiple blood samples (n = 79) were collected at ran-
dom intervals from 5 women during active physiological
labour and birth. Oxytocin levels in plasma averaged 181
μU/mL (range 35–435 μU/mL) in 79 samples. The vari-
ation between samples was enormous, indicative of a
pulsatile release of oxytocin. The data obtained in this
study could not determine whether oxytocin levels were
higher during labour than during pregnancy, perhaps
due to the wide between-sample variations.
In relation to oxytocin in pregnancy, levels rose from
66 μU/mL to 165 μU/mL between weeks 4 and 40 (n =
280). The main rise was observed between weeks 25 and
40. There was a significant correlation between oxytocin
levels and weeks of gestation (p < 0.01). Oxytocin levels
were less than 1.0 μU/mL (n = 15) in non-pregnant
women. Note that there was a marked difference be-
tween oxytocin levels in non-pregnant and pregnant
women.
Kumaresan et al. 1975 [15]
Serial blood samples were collected from 29 women,
from physiological labour and birth to 4 days postpar-
tum. Mean oxytocin levels were approximately the same
10min before and directly after birth: 90 ± 11 μU/mL
and 82 ± 12 μU/mL respectively. Oxytocin levels de-
creased gradually postpartum (day 1–66 ± 8 μU/mL, day
2–50 ± 9 μU/mL, day 3–54 ± 9 μU/mL and day 4, the
same as day 3). The fall in oxytocin levels between day 1
and days 2, 3 and 4 was significant (p < 0.01). Lower oxy-
tocin levels postpartum indicates that oxytocin levels
were raised during labour.
Gibbens et al. 1976 [16]
Serial blood samples (8) were collected from 97 women
during physiological labour and birth. Oxytocin levels
were not detected in all samples, likely due to its pulsa-
tile release. A progressive increase in the number of
positive results was apparent throughout the first and
second stage of labour, suggesting that oxytocin levels
increase during the course of labour. Oxytocin levels, in-
dicating the size of pulses, varied between 2 and 12.5
μU/mL. A decrease in oxytocin levels was seen in the
third stage of labour. There was no obvious relationship
Table 2 Characteristics of included studies
First author,
year, ref. no.
Data collection Methodology Comment
Coch 1965
[13]
Blood samples from the jugular and a peripheral vein at
various stages of labour and postpartum, in 18 women.
Bioassaya Bioassay based on milk ejection in rabbits calculating
“oxytocin equivalent activity.” Very high levels compared to
modern assays using RIA.
Kumaresan
1974 [14]
Single blood samples between weeks 4 and 40 during
pregnancy in 280 women.
79 random samples during active labour in 5 women.
Serial samples were obtained before and after oxytocin
infusion of 100 mU per min to women with mid-
pregnancy terminations.
RIAb OT determinations performed with RIA without prior
extraction, explaining why high levels. OT levels were
already very high at term, but did not rise further during
labour, maybe due to an insensitivity of this assay at high
levels of OT.
Kumaresan
1975 [15]
Single maternal blood samples were collected from 29
women 10 min before birth, just after birth and daily for 4
days postpartum.
RIAb OT determinations performed with RIA without prior
extraction, giving higher levels. Lack of a significant peak
at birth suggests possible insensitivity of the assay at high
levels.
Gibbens
1976 [16]
8 serial blood samples from 97 women during
spontaneous labour (1st stage 33, 2nd stage 14, 3rd 10).
Single samples from a further 30 women during the 3rd
stage of labour. The serial samples were collected over a
period of 4 to 8 min.
RIAc Pulsatile release of OT was detected. Very low basal levels
of OT may be due to insensitivity of the RIA used, or to a
loss of OT during the extraction procedure.
Vasicka
1978 [17]
Blood samples were collected in a longitudinal study
(during pregnancy, onset of labour and birth) in 15
women. Samples at one- to two-week intervals during
pregnancy and one minute to one hour intervals through-
out labour and birth.
RIAb OT determinations performed with RIA without prior
extraction, explaining high levels.
Dawood
1979 [18]
362 blood samples were collected from normal pregnant
women.
Serial blood samples of blood were obtained from 10
pregnant women through gestation until labour onset.
Serial samples taken at 1 min intervals over a 10min
period in 7 pregnancies and 3 in 1st stage of labour.
RIAc OT levels recorded within the range normally observed
with established RIA after prior extraction of the samples.
Leake 1981
[19]
Plasma oxytocin levels in 102 non-pregnant women, 20
women receiving oral contraceptive medications and 59
pregnant women from 15 to 42 w of pregnancy. Repeated
samples were collected in 38 healthy women during spon-
taneous labour.
RIAc Very low OT levels. RIA did not pick up differences
between pregnant and non-pregnant women; the rise of
oxytocin occurring during pregnancy; or the rise of OT ob-
served during labour, suggesting that the RIA used was
very insensitive. Significant rise of OT level observed was in
connection with birth only.
Otsuki 1983
[20]
Individual samples from 38 normal pregnant women
between the 15th and the 41 st w of pregnancy. Serial
samples from 2 women in the mid trimester, from 4
women at term without labour contractions and from 6
women in the 1st stage of normal spontaneous labour, at
10 s intervals over a period of 2–3 min.
RIAc Relevant OT levels within the range normally observed
with established RIAs.
Goodfellow
1983 [21]
20 primigravidae with normal labour, after 37 to 41 weeks
of pregnancy.
Epidural analgesia was chosen by half of the women.
Blood samples at the beginning and end of 2nd phase of
labour.
RIAc Relevant OT levels within the range normally observed
with established RIA.
Husslein
1983
[22]
20 women with spontaneous labour. Blood samples were
collected just before the 2nd phase of labour, 5 min
postpartum, 30min after expulsion of placenta and 2 h
after birth. 7 women received oxytocin drip in a low
dosage at the end of the first phase of labour. Directly
after birth 10 women received oxytocin drip in a high
dosage (100-150mIU/min).
RIAc Relevant OT levels giving values within the range normally
observed with established RIA.
Fuchs 1983
[23]
17 women in early spontaneous labour and 15 women at
term who were given oxytocin induction.
Five blood samples. In one group at admission to the
labour ward and subsequent samples were taken at 1–3 h
intervals. In another group a blood sample just before
infusion of oxytocin was started and thereafter just before
the infusion rate was increased. Infusion was begun at the
rate of 1–2 mU/min and increased stepwise every 15 min
until contractions occurred with about 3 min intervals.
RIAc Relevant OT levels within the range of values normally
observed with established RIA.
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Table 2 Characteristics of included studies (Continued)
First author,
year, ref. no.
Data collection Methodology Comment
Thereafter the infusion rate was kept constant.
10 of these 17 women contributed a blood sample 1–2 w
before labour.
The control group consisted of 4 pregnant women at term
but not in labour. Four serial samples were taken at 2 h
intervals from each woman.
Amico 1984
[24]
Eleven women with “hypocontractile labour” received
oxytocin infusion in a dose of 1 mU/min and it was
increased by one 1mU every 40min until adequate
contractions were observed.
Blood samples were drawn before start of infusion and at
every 20 min, during infusion and for 60 min after the end
of infusion.
RIAc Very low basal levels of OT maybe due to insensitivity of
the RIA used or to loss of OT during the extraction
procedure.
Takeda
1985 [25]
42 participants were included in the study, 4 healthy
males, 15 non-pregnant women, and 23 pregnant women
(11 before and 12 in labour).
Blood and cerebrospinal fluid (CSF) samples were collected
simultaneously from all the participants.
RIAc Relevant OT levels within the range of values normally
observed with established RIA.
Takagi 1985
[26]
36 women were included in the study (7 non pregnant
women, 11 pregnant women having an emergency CS
and 18 pregnant women having an elective CS.
1 blood and cerebrospinal fluid (CSF) samples were
collected simultaneously from all the women
RIAc Relevant oxytocin levels within the range of values
normally observed with established RIA.
De Geest
1985 [27]
10 pregnant women and 15 women during normal labour,
5 of which received EDA. Four blood samples during
pregnancy and during the 1st and 2nd stage of labour.
Blood samples were also collected from umbilical arterial
and venous blood vessels after birth
RIAb OT determinations performed with RIA without prior
extraction, which explains high OT levels. A rise of OT level
observed during pregnancy, but not during labour,
suggesting that the RIA used was insensitive at higher
levels than those observed during pregnancy.
Kuwabara
1987 [28]
Repeated blood samples in 6 normal pregnant women
and blood samples were taken in 7 normal pregnant
women every 2 days for at least 14 days before the onset
of labour. Simultaneous blood samples were collected
from maternal venous blood, umbilical arterial and venous
vessels in 10 normal deliveries, 15 elective caesarean
sections, and 5 emergency caesarean sections. Amniotic
fluid samples were collected during pregnancy and in
elective caesarean sections. Blood samples were also
collected from 10 non-pregnant women.
RIAc Relevant OT levels within the range of values normally
observed with established RIA.
Thornton
1988 [29]
25 women having spontaneous labour, of these 10
women received synthetic OT i.m. when the anterior
shoulder was delivered. Blood samples were collected
every 30th second (for 15 min) after crowning of the head.
RIAc Low, but relevant OT levels within the range of values
observed with established RIA.
Oosterbaan
1989 [30]
Maternal venous blood was collected at the time of
amniocentesis (n = 17), elective CS (n = 18) and/or immediately
after normal birth of the baby (n = 44). Mixed cord blood or
blood from the umbilical artery or vein was collected at the
time of elective CS or after spontaneous birth of the baby.
RIAc Relevant OT levels within the range of values normally
observed with established RIA.
Fuchs 1991
[31]
50 pregnant women (38 to 42 weeks of gestation)
Samples were collected with 1 min intervals for 30 min
from the following groups:
1) Women at term who were scheduled for elective CS,
with a closed cervix and not in labour (n = 11).
2) Women in the 1st stage of spontaneous labour with <
6 cm cervical dilation (n = 13)
3) Women in the 2nd stage of spontaneous labour with
full dilatation of the cervix (n = 8). Five of these women
delivered during the 30 min long sampling period and
therefore samples were collected also after birth until
delivery of the placenta.
4) 18 women who were not in labour were give bolus
injections of OT iv, 2, 4, 8 or 16 mU.
8 blood samples before and 30 s, 1, 2, 3, 4, 5 and 10 min
after injection (n = 18).
RIAd Very low basal levels of OT perhaps due to insensitivity of
the RIA used or a loss of OT during the extraction
procedure. Frequent sampling of blood, together with low
basal levels of OT, allowed recording and quantitative
analysis of individual OT pulses.
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Table 2 Characteristics of included studies (Continued)
First author,
year, ref. no.
Data collection Methodology Comment
Stocche
2001 [32]
30 women included in a randomized open label. Each
women was in spontaneous labour at > 5 cm cervix
dilatation.
Patients received either intrathecal sufentanil 10
microgram or epidural plain bupivacaine 0.25%
Serial blood samples were collected before analgesia and
15, 30, 60 and 90 min after the induction of the analgesia.
RIAc Low, but relevant OT levels within the range of values
observed with established RIA.
CS caesarean section, min =minute/s, hrs = hours, w = weeks, EDA = epidural analgesia, OT = oxytocin
aOxytocin like activity was measured by bioassay
bRadioimmunoassay performed on unextracted plasma
cRadioimmunoassay performed on extracted plasma
dRadioimmunoassay performed on extracted plasma. Note that the antibody does not, measure the type of oxytocin released during pregnancy
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uterine contractions.
Vasicka et al. 1978 [17]
Serial blood samples were collected from 15 women dur-
ing physiological labour and birth. No surge of oxytocin
was observed at the onset of labour, suggesting that
other factors than a rise oxytocin may be responsible for
initiation of labour. Oxytocin levels varied between 64
and 148 μU/mL during labour. The most extensive re-
lease of oxytocin was seen in connection with maximal
cervical and vaginal distention in 12 of the 15 women.
The substantial rise of oxytocin levels in connection with
birth most likely corresponds to the Ferguson reflex.
Oxytocin levels were also measured in pregnancy, and
increased from 126.9 ± 21.1 μU/mL in gestational week
24 to 153.0 ± 26.6 μU/mL in week 40 (n = 15). While
oxytocin levels rose during pregnancy, the relationship
between oxytocin levels and gestational age did not
reach statistical significance. Two spikes per patient were
observed during gestational weeks 24 to 34 and from 36
weeks progressively increasing oxytocin levels were
found in three consecutive samples collected with 1
week intervals.
Dawood et al. 1979 [18]
Serial blood samples were collected every minute, during
a 10-min period, from 7 women during pregnancy and
physiological labour and birth. The release of oxytocin
was episodic with a frequency of 2–3 “spurts” (pulses)
per 10 min. The levels of oxytocin varied between 0 and
86 pg/mL during labour (n = 3). There was no obvious
connection in time between oxytocin levels and uterine
contractions.
Plasma levels of oxytocin during pregnancy rose from
17.9 ± 2.1 pg/mL (weeks 1–20) to 28.9 ± 4.7 pg/mL
(weeks 21–30) and to 32.9 ± 2.9 pg/mL (weeks 31–32)
(n = 362). There was a highly significant correlation be-
tween the mean maternal plasma oxytocin and the week
of gestation (p < 0.005). A marked increase in maternal
oxytocin levels to 74.2 ± 14.2 pg/mL was observed at 39weeks of gestation, compared to the levels at 38 weeks
(26.4 ± 4.8 pg/mL). A significant drop in levels from 39
to 40 weeks of gestation was also found. When sampling
was performed every minute, 2–3 pulses per 10 min
were observed. The amplitude of the pulses was greater
during labour than in samples collected during preg-
nancy according to the same time schedule.
Leake et al. 1981 [19]
Blood samples were collected from 59 pregnant women,
and serially from 50 women at the onset, peak and immedi-
ately after, individual contractions, at several times during
physiological labour and birth. The oxytocin concentrations
were 1.3 ± 0.2 μU/mL (n = 6) 1.6 ± 0.2 μU/mL (n = 14) dur-
ing the latent and active phases of labour respectively, and
1.1 ± 0.1 μU/mL (n = 19) at the time of initial visualization
of the fetal head. During birth of the fetal head, there was a
significant 4-fold rise in plasma oxytocin to 4.2 ± 1.1 μU/
mL (n = 11), compared to the levels obtained at the time of
initial visualization of the fetal head (p < 0.05).
Average oxytocin levels measured during a single uter-
ine contraction during the latent or active phase of
physiological birth were 1.5 ± 0;3 μU/mL before, 1.4 ± 0.2
μU/mL at the peak and 2.0 ± 0.3 μU/mL after the contrac-
tion. This indicates no immediate correlation in time be-
tween plasma oxytocin levels and uterine contractions.
Average oxytocin levels in women between 15 and 42
weeks’ gestation were 1.3 ± 0.1 μU/mL (n = 59), and in
non-pregnant women, 1.4 ± 0.2 μU/mL (n = 102). Plasma
oxytocin levels obtained during labour did not differ
from the levels obtained during pregnancy or from the
levels observed in non-pregnant women, 1.3 ± 0.1 μU/
mL, nor was there any significant difference between
oxytocin levels in pregnant and non-pregnant women.
Otsuki et al. 1983 [20]
Serial blood samples were collected from 2 subjects in
the mid trimester, from 4 subjects at term without
labour contractions, and from 6 subjects in the first
stage of normal, physiological birth. Blood was taken at
10 s intervals over a period of 2–3 min.
Table 3 Oxytocin levels in blood samples collected during physiological birth in the 20 selected papers. Values from pregnant and
non-pregnant women are included. All values are presented in pg/mL, with SD or range in parentheses
First author, year Labour and birth (pg/mL) Time for blood sample Pregnancy (pg/mL) Gestational week (w) Non-pregnant (pg/mL)
Coch 1965 [13]a 167 Active labour
Kumaresan 1974 [14]a 302 (58.3–725.0) Active labour 110 4 w < 1.7
275 40 w
Kumaresan 1975 [15]a 150.0 (18.3) 10 min before birth
136.7 (20.0) Immediately after birth
Gibbens 1976 [16]a 4.2–20.8 1st – 3rd stage
Vasicka 1978 [17]a 73.3–273.3 Active labour 211.5 (35.2) 24 w
255.0 (44.3) 40 w
Dawood 1979 [18] 0–86 1st stage of labour 17.9 (2.1) 1–20 w
28.9 (4.7) 21–30 w
32.9 (2.9) 31–32 w
26.4 (4.8) 38 w
74.2 (14.2) 39 w
Leake 1981 [19]a 2.2 (0.3 Latent phase 2.2 (0.2) 15–42 w 2.3 (0.3)
2.7 (0.3) Active labour
1.8 (0.2) Visible head
7.0 (1.8) Delivery of head
Otsuki 1983 [20]a 21.0 (63.3–146.7) Active labour 8.3 20 w
20.8 (12.8) 36–41 w
Goodfellow 1983 [21] 7.2–46.0; Full dilatation
8.8–85.0c Crowning of head
Husslein 1983 [22] 50.7 (10.7)
29.1 (9.7)
Full dilatation
30 min postpartum
Fuchs 1983 [23] 45 (3.9)
21.1 (6.4)
49.1 (10.9)
58.8 (9.9)
110 (22.7)
1st stage
1–3 mU/min SOT inf
4–6 mU/min SOT inf
7–9 mU/min SOT inf
10–15 mU/min SOT inf
15.4 (8.7)
17.4 (4.8)
19.9 (3.1)
1–2 weeks before labour
Before induction
At term
Amico 1984 [24]a 1.7 (0.5) Arrest in active labour
Takeda 1985 [25]a 32.8 (5.5) Active labour 26.8 (4.8) 7–41 w 8.0 (0.8)
Takagi 1985 [26]a 75.3 (32.7) Before emergency CS 11.7 (8.8)
De Geest 1985 [27]a 276.7 < 3 cm cx dilatation 78.3 8–12 w
298.3 5–7 cm 128.3 20–24 w
281.7 10 cm 208.3 30–34 w
276.7 2nd stage 226.7 38–42 w
Kuwabara 1987 [28]a 51.0 (8.3) Immediately after birth 27–28 6–41 w 6.8 (0.8)
33.3 At term
Thornton 1988 [29]b 3.2 (2) Crowning of head
6.4 (2) After delivery of shoulder
11.6 Mean peak after birth
Oosterbaan 1989 [30] 65 (9)
12 (9)
Immediately after birth
During prelabour CS
Fuchs 1991 [31]a 1.8 (0.2) 1st stage < 6 cm 1.5 (0.5) At term before elective CS
2.3 (0.6) 2nd and 3rd stage
Stoche 2001 [32] 7.4 (2.1) 1st stage
6.6 (3.1) Before analgesia
pg/mL picograms per millilitre, mU/min milliunits per minute, SOT inf synthetic oxytocin infusion, CS caesarean section, μU/mL microunits per millilitre, pmol/L
picomoles per litre
aOxytocin levels have been converted from μU/mL to pg/mL
bOxytocin levels have been converted from pmol/L (pM) to pg/mL
cCorrected from Table 1 in Goodfellow 1983
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Table 4 Summary of oxytocin levels during labour and birth
(converted to pg/mL)
Oxytocin levels varied significantly between the studies. Very low values
around 1.7–3.4 pg/mL were reported by: Leake 1981 [19], Amico 1984
[24], and Fuchs 1991 [31]. Very high levels, around 167–340 pg/mL, were
reported by Coch 1965 [13], Kumaresan 1974 [14] and 1975 [15], Vasicka
1978 [17], and De Geest 1985 [27]. These high levels were obtained
using bioassay or RIA without previous extraction of the plasma
samples, which likely explains the higher-than-expected results.
The majority of the articles report the levels as expected, between 17
and 85 pg/mL; Gibbens 1976 [16], Dawood 1979 [18], Otsuki 1983 [20],
Goodfellow 1983 [21], Husslein 1983 [22], Fuchs 1983 [23], Takeda 1985
[25], Takagi 1985 [26], Kuwabara 1987 [28], Thornton 1988 [29],
Oosterbaan 1989 [30], and Stoche 2001 [32].
Difference in oxytocin levels between pregnancy and labor
A rise of oxytocin levels between pregnancy and labor was observed by
Dawood 1979 [18], Husslein 1983 [22], Fuchs 1983 [23], and Fuchs 1991
[31].
No rise was observed by Kumaresan 1974 [14] and 1975 [15], and De
Geest 1985 [27], which was most likely due to a lack of sensitivity of the
assay used.
Difference in oxytocin levels over time during labor, or between the 1st and
the 2nd stage of labor
A rise of oxytocin levels during labor was observed by Coch 1965 [13]
and Gibbens 1976 [16].
In addition, Dawood 1979 [18], Otsuki 1983 [20], and Fuchs 1991 [31]
found an increasing incidence, frequency, and/or amplitude of oxytocin
pulses, from late pregnancy through to the first and second phases of
labor. Fuchs 1991 [31] found a maximum pulse frequency of 3 per 10
min in late labor.
Rise of oxytocin levels in connection with birth
A very pronounced rise of oxytocin levels (sometimes as much as a 4-
fold increase) was observed in connection with birth of the baby, com-
pared to levels in pregnancy, early labor, or immediately following PLCS:
Vasicka 1978 [17], Leake 1981 [19], Goodfellow 1983 [21], Husslein 1983
[22], Kuwabara 1987 [28], Thornton 1988 [29], Oosterbaan 1989 [30].
Elevation of oxytocin levels in connection with expulsion of the placenta or
postpartum
In some studies, elevated oxytocin levels were also found during the
third stage of labor, likely in connection with expulsion of the placenta
(Kumaresan 1975 [15], Husslein 1983 [22], Thornton 1988 [29], Fuchs
1991 [31])
Table 6 Summary of the occurrence of uterine contractions in
relation to plasma levels of oxytocin during labour without and
with synthetic oxytocin
Dissociation between oxytocin levels and uterine contractions
The time relationship between oxytocin levels and uterine contractions
was studied in 4 of the articles. In all of these studies, no association
was found between oxytocin peaks and uterine contractions: Gibbens
1976 [16], Dawood 1979 [18], Leake 1981 [19], Otsuki 1983 [20].
Effect of synthetic oxytocin administration on oxytocin levels and
uterine contractions
Infusions of synthetic oxytocin at a rate of 4–6 mU/minute gave rise to a
significant rise in oxytocin levels in women at term without labour,
which corresponded to the oxytocin levels seen during physiological
labour. At an infusion rate of 10–16mU/min, oxytocin levels were higher
than physiological levels (Fuchs 1983 [23]). Doubling the dose lead to
doubled levels (Fuchs 1983 [23]), Amico 1984 [24]), Bolus injections of
4–8 mU of synthetic oxytocin in women at term, without labour gave
rise to an increase of oxytocin levels of the same size as observed
during physiological oxytocin pulses and was associated with uterine
contractions. (Fuchs 1991 [31]).
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the first stage of physiological labour, with fluctuations
and sometimes spurt releases observed. The size of the
spurts in active labour varied between 38 and 88 μU/
mL. No correlation in time was observed between spurts
or fluctuations of oxytocin levels and uterine contrac-
tions. The mean level of oxytocin was 12.1 μU/mL dur-
ing uterine contractions and 11.5 μU/mL during
relaxation.
Plasma levels of oxytocin during pregnancy showed a
gradual rise from 5 μU/mL at week 20 to 12.5 ± 7.7 μU/Table 5 Summary of oxytocin levels during pregnancy and in
non-pregnant women
In the studies by Kumaresan 1974 [14], Vasicka 1978 [17], Dawood 1979
[18], Otsuki 1983 [20], De Geest 1985 [27], and Kuwabara 1987 [28], a rise
of oxytocin levels was recorded with advancing pregnancy. These data
demonstrate that oxytocin levels increase during pregnancy. Regardless
of the basal levels, and the type of technique used for analysis of
oxytocin levels, oxytocin levels increased about 2 to 4-fold. Oxytocin
levels in non-pregnant women varied between 1.7 and 11.7 pg/mL.mL at term (n = 38). There was no difference between
the mean level of oxytocin at term (12.5 μU/mL) and
during the first stage of physiological labour ((12.6 μU/
mL). Almost no fluctuations of oxytocin levels were ob-
served at mid-pregnancy, whereas substantial fluctua-
tions were seen at term. Compared with labour, the
oxytocin fluctuations were not small at term, but the
pulse phenomenon was more often detected amongst
women who were in labour (3/6), compared to those not
in labour (1/4).
Goodfellow et al. 1983 [21]
Serial blood samples were collected from 10 women at
the beginning and at the end of the second stage of
physiological birth (crowning of the head). Oxytocin
levels at full dilatation were between 7.2 and 46.0 pg/mL
and at crowning between 2.3 and 85.0 pg/mL. The rise
in oxytocin levels between full dilatation and crowning
was significant.
Husslein et al. 1983 [22]
Blood samples were collected from 20 women in physio-
logical labour and 14 pregnant women at term but not
in labour. Of these, 7 women received an infusion with
synthetic oxytocin in a low dosage at the end of the first
stage of labour, and directly after birth 10 women re-
ceived an oxytocin infusion in a high dosage (100-
150mIU/min). Plasma oxytocin levels at full cervical
dilatation (50.7 ± 10.7 pg/mL) were significantly raised
over oxytocin levels at term (18 ± 3.2 pg/mL) and had
returned to levels observed at term 30min postpartum
(29.1 ± 9.7 pg/mL). Taken together the data demonstrate
a substantial rise of oxytocin levels during birth.
Fuchs et al. 1983 [23]
Serial blood samples were collected from 17 women in
early physiological labour and 15 women at term in
Fig. 2 Schematic figure of oxytocin levels (relative values), and oxytocin pulse frequency, averaged over 30min, in pregnancy and physiological
labour and birth. Data compiled from Fuchs 1991 [31] in relation to: term pregnancy (1); first stage labour (2); second stage labour (3). Data in
relation to birth (4) compiled from studies cited in Box 1: Rise of oxytocin levels in connection with birth
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indicated. In both groups the first sample was collected
at admission to the labour ward, and four subsequent
samples were collected at 1–3 h intervals. An additional
blood sample had been collected 1 or 2 weeks before
labour in 10 of the 17 women in the physiological labour
group. Synthetic oxytocin infusion was begun at a rate
of 1–2mU/min and was increased stepwise every 15
min. Four pregnant women at term but not in labour
served as controls. In this group four blood samples
were taken2-hour intervals.
During the first stage of physiological labour, the mean
concentration of oxytocin was 45.0 ± 3.9 pg/mL. These
levels were significantly higher than oxytocin levels ob-
tained in the same women 1–2 weeks before labour
(15.4 ± 8.7 pg/mL) and was higher than the mean con-
centration in the control (pre-labour) group (19.9 ± 3.1
pg/mL). Plasma levels of oxytocin were already raised
over control levels in the first sample collected during
early labour and remained at approximately the same
level throughout the study. In conclusion plasma oxyto-
cin levels recorded during labour were higher than those
observed during pregnancy or at term.
In the synthetic oxytocin infusion group, basal levels
of oxytocin were 17.4 ± 4.8 pg/mL. Infusions of synthetic
oxytocin at a rate of 4–6 mU/min significantly raised
oxytocin levels to 49 ± 10.0 pg/mL. Plasma oxytocin
levels during physiological labour were comparable to
those produced by an infusion of synthetic oxytocin at a
rate of 4–9 mU /minute. Infusion rates at 10-16 mU/mi-
nute gave rise to oxytocin levels that were twice as high(110 ± 10.9 pg/mL). It was further calculated that en-
dogenous oxytocin is released at a rate of 1 mU/min
under basal conditions in pregnant women.
Amico et al. 1984 [24]
Serial blood samples were collected from 11 women
with “hypocontractile labour” (arrested progress) in the
active phase of physiological labour. Synthetic oxytocin
was infused in increasing doses from 1 to 5 mU/min and
repeated plasma samples were collected before and dur-
ing the infusions. The level of oxytocin before infusion
with synthetic oxytocin was 1.01 ± 0.31 μU/mL.
In relation to women receiving an infusion with syn-
thetic oxytocin, there was a linear relationship between
dosage of infusion of synthetic oxytocin and oxytocin
levels. A steady state concentration was found by 40 min
following infusion rate changes. However, the rate of in-
fusion in individual women’s, oxytocin levels at the time
of “adequate contractions” was very variable, ranging
from 0.90–5.06 μU/mL. This 5-fold variability suggests
significant differences in oxytocin effects, likely reflecting
differing numbers and/or binding of oxytocin receptors.
Takeda et al. 1985 [25]
Plasma and CSF samples were collected from 11 preg-
nant women during gestational weeks 7–41 and from 12
women in physiological labour. Plasma levels and CSF
levels of oxytocin were 16.1 ± 2.9 μU/mL and 9.7 ± 1.5
μU/mL respectively in pregnant women, and 19.7 ± 3.3
μU/mL and 18.6 ± 2.3 μU/mL in women in labour. Com-
paring oxytocin levels in women in labour vs pregnancy,
ab
Fig. 3 a Oxytocin levels in physiological labour. Means from samples
collected 5 times from 17 women over the duration of first stage.
Note that peaks are not observed because samples were collected
at long intervals. Adapted from Fuchs 1983 [23]. b Oxytocin levels
with synthetic oxytocin infusion. Means from samples collected 5
times from 15 women induced with synthetic oxytocin. Samples
were collected, as indicated by arrows, before infusion begun at 1-3
mU/min, and at the end of each infusion period (before the next
increase). Adapted from Fuchs 1983 [23]
Fig. 4 Oxytocin levels in physiological labour. Serial samples
collected every 1 min over 10 min from one woman. Adapted from
Dawood 1979 [18]
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labour, but plasma levels did not differ from pregnancy
to labour. This suggests that there is an increased release
of oxytocin into the CSF during labour and that there
may be differential control of the release of oxytocin into
the circulation and CSF. Plasma levels of oxytocin were
4.8 ± 0.5 μU/mL (n = 15) in non-pregnant women.
Takagi et al. 1985 [26]
Plasma and CSF samples were collected from 11 women
before emergency caesarean section (EmCS), who had
uterine contractions, and from 18 women before prela-
bour caesarean section (PLCS, elective caesarean), who
had no uterine contractions.
Mean plasma levels of oxytocin before EmCS and
PLCS were 45.2. ±19.6 μU/mL, and 17.1 ± 22.2 μU/mL
respectively Mean CSF levels of oxytocin before EmCS
and PLCS were 4.9 ± 4.1 μU/mL and 4.1 ± 2.4 μU/mL re-
spectively. Comparing oxytocin levels in women with
and without labour contractions, plasma levels werehigher in women with uterine contractions, whereas no
difference in CSF levels was found in this study. Plasma
oxytocin levels in non-pregnant women were 7 ± 5.3 μU/
mL (n = 7).
De Geest et al. 1985 [27]
Repeated blood samples were collected from 10 women
during pregnancy and 10 women during physiological
labour and birth. No consistent rise of oxytocin levels
was observed during labour. Oxytocin levels were 166 ±
29 μU/mL, 179 ± 29μU/mL, 169 ± 25 and 166 ± 30 μU/
mL at cervical dilatation < 3 cm, 5–7 cm, and 10 cm and
during the second stage of labour respectively.
In pregnancy, oxytocin levels averaged 47, 77, 125 and
136 μU/mL at, 8–12, 20–24, 30–34 and 38–42 weeks of
gestation respectively (n = 10). The rise of oxytocin levels
over time during pregnancy was significant (p < 0.01).
Kuwabara et al. 1987 [28]
Serial blood samples were collected from 10 pregnant
women over the last 14 days before the onset of physio-
logical labour and also 6 h after onset of labour. In
addition, maternal blood samples were collected imme-
diately after spontaneous birth (n = 10), PLCS (n = 15)
and EmCS (n = 5).
Oxytocin levels were around 20 μU/mL at term, with
levels the same at 6 h after onset of labour, indicating no
rise of oxytocin levels at this time-point, compared to
term. Oxytocin levels were 30.6 ± 5.0 μU/ml after
physiological labour and birth; 22.6 ± 1.4 μU/mL after
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tocin levels after physiological labour and birth were sig-
nificantly higher (p < 0.05) than following PLCS. These
results indicate that oxytocin levels are elevated at the
end of labour.
Six pregnant women provided 36 blood samples dur-
ing weeks 6–41 of gestation. Ten blood samples were
collected from normal non-pregnant women.
Oxytocin levels rose progressively during pregnancy,
from 4.1 ± 0.5 μU/mL in non-pregnant women (n = 10)
to around 16–17 μU/mL at week 40 of gestation, and
there was a significant correlation between oxytocin
levels and week of gestation (p < 0. 01). There was no
change in oxytocin levels during the last 14 days of preg-
nancy, and there was no diurnal variation.
Thornton et al. 1988 [29]
Serial blood samples were collected every 30 s for 15
min during the late second stage of labour, and through-
out the third stage of labour in 15 women.
Oxytocin levels were 3.2 (±2) pmol/L in connection
with crowning of the fetal head and 6.4 (±2) pmol/L)
after birth of the anterior shoulder (p < 0.01). A peak of
oxytocin was seen a few minutes later with a mean oxy-
tocin concentration of 11.6 (±1.5) pmol/L. The data
show that there is a substantial rise of oxytocin levels in
connection with birth. This oxytocin peak occurs after
birth rather than before, suggesting that it is a conse-
quence of the Ferguson reflex, activated as the baby is
born.
Oosterbaan et al. 1989 [30]
Blood samples were collected in 12 women immediately
after physiological labour and birth and 11 women after
PLCS. Oxytocin levels after physiological labour and birth
were 65 ± 9 pg/mL and were significantly higher than
those observed after PLCS, 12 ± 9 pg/mL (p < 0.009).
These results suggest that oxytocin levels are elevated
during physiological labour and birth.
Fuchs et al. 1991 [31]
Blood samples were collected at 1 min intervals for 30
min in 11 pregnant women at term with a closed cervix
who were scheduled for PLCS; in 13 women in the first
stage of physiological labour with less than 6 cm cervical
dilatation; and in 8 women in the second stage of
physiological labour with full dilatation of the cervix.
Plasma levels of oxytocin were below the detection
limit, 0.17 μU/mL, in 85% of the samples in the preg-
nancy group, in 30% of the samples in the first phase of
labour and in 16% of the samples collected during the
second and third stage of labour. Levels above 0.45 μU/
mL were considered pulses. Discrete pulses were ob-
served in all groups and occurred at irregular intervalsand had variable amplitudes. All pulses were of short
duration, 2–3 min.
The frequency of pulses per 30 min was lowest in the
no labour group (1.2 pulses ±0.54); higher in first stage
of labour at 4.2 pulses ±0.54; and maximal during the
second and third stage of labour at 6.5 pulses ±0.49. The
difference in frequency of pulses between the three
groups was highly significant.
The mean pulse amplitudes in women not in labour;
in first stage; and in second and third stages were 0.91 ±
0.20 μU/mL, 1.10 ± 0.10 μU/mL, and 1.40 ± 0.35/mL re-
spectively. The mean duration of the pulses was also in-
creased in women in labour (1.9 ± 0.21min) in
comparison to women not in labour (1.2 ± 0.14 min).
As a result of the higher amplitude and duration of
pulses, the overall mean plasma oxytocin levels were sig-
nificantly higher in women in labour than in women not
in labour. The mean amount of oxytocin released over
30 min (μU/mL) was 0.26 ± 0.041; 0.42 ± 0.04; and
0.65 ± 0.12 in women with no labour; in the first stage of
labour; and during the second and third stages of labour
(combined) respectively.
Bolus injections of synthetic oxytocin were given to 18
women who were not in labour at 2, 4, 8 and 16mU
dosage. A significant rise of oxytocin was detected in those
receiving 4, 8 and 16mU of synthetic oxytocin. Peaks in
oxytocin occurred 30–60 s after injection. The peaks
induced by 4 and 8mU of synthetic oxytocin were of the
same size as the physiological peaks during labour (around
1.1microU/mL). These bolus injections stimulated uterine
contractions. The average the number of contractions in
the first 10min after the injection was correlated with the
mean peak plasma level in each group.
Stocche et al. 2001 [32]
Blood samples were collected from women during
labour, both before and after administration of two types
of analgesia in this randomized, open-label study. Oxyto-
cin levels during the first stage of labour were similar in
the two groups of women before administration of
analgesia; 7.4 ± 2.1 pg/mL (n = 15) and 6.6 pg/mL ±3.1
(n = 15).
Discussion
Summary of results
Based on a systematic review on plasma levels oxytocin
in physiological labour and birth, we summarize the data
as follows: Basal oxytocin levels rise during pregnancy.
Oxytocin levels increase during labour. Pulses of oxyto-
cin occur with increasing frequency, amplitude, and dur-
ation from the end of pregnancy towards the end of the
second stage of labour. The maximal frequency of pulses
is 3 per 10 min. A pronounced (four-fold) rise of oxyto-
cin occurs in connection with birth. Oxytocin is also
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connection with expulsion of the placenta. Oxytocin
pulses are not directly in time associated with uterine
contractions. Infusion of synthetic oxytocin at a rate of
4–9 mU/minute gives rise to oxytocin levels equivalent
to levels during physiological labour. Oxytocin levels
double in response to doubling of the infused dose. Ad-
ministration of 4–8mU of synthetic oxytocin as an
intravenous bolus injection gives rise to peaks of oxyto-
cin that are equivalent in size to peaks that occur during
physiological birth and stimulate uterine contractions.
Oxytocin levels in CSF rise during labour and birth.
Methodological considerations
The studies that are described and analysed in this sys-
tematic review are mainly of explorative research design,
and may at first sight seem less sophisticated, compared
to contemporary randomized controlled studies. How-
ever, these studies are of high quality. It is important to
realise that measuring oxytocin levels in repeated sam-
ples during the long duration of labour and birth is ex-
tremely complex, not only because of the intrinsic
challenges of sampling blood in a labouring woman, but
also because of ethics, expense, and the complex bio-
analytic methods that are required.
The design and content of the studies vary consider-
ably, and therefore the studies are difficult to compare in
a systematic way, and also a standard quality assessment
of the articles was not possible to carry out. The studies
included single oxytocin levels obtained during labour,
as well as sequences of oxytocin levels obtained during
pregnancy and labour, with time intervals varying from
weeks to minutes, even seconds. In addition, the in-
cluded studies used different techniques for oxytocin
measurement, giving numerical differences in oxytocin
levels, and even different effect patterns. Some of these
differences are related to the technology and assays
available at the time of the study. Generally, more recent
studies have used more accurate measurement tools, as
discussed below. Because of these differences, data from
articles using different methods cannot be collated.
The first methods used to determine oxytocin levels in
blood were based on biological activity. For example,
“oxytocin equivalent activity” measured the effect of oxy-
tocin to stimulate milk ejection in lactating rabbits [13].
Such techniques are complicated and relatively unspe-
cific and insensitive. Subsequently, immunological tech-
niques were developed such as radioimmunoassay (RIA),
which measures the propensity of the oxytocin in plasma
samples to influence the binding between antibodies to
oxytocin and radioactive oxytocin. With the develop-
ment of RIA, increasingly smaller amounts of oxytocin
could be measured. However, these techniques are not
completely specific, and it is possible that othersubstances in plasma might influence the binding be-
tween oxytocin and its antibodies, and affect the results
obtained. Extraction of the plasma samples prior to the
assays was introduced to reduce this risk and increase
the specificity of the RIA. Another factor that may influ-
ence the results is the specificity of the antibodies that
react with oxytocin in the radioimmunoassay. This may
explain the variation in the included studies, as to basal
levels of oxytocin obtained with different assays, but also
in the patterns of effect [31].
Enzyme-linked immunosorbent assay (ELISA, EIA) is
another type of immunological method used to measure
oxytocin levels. Studies using ELISA have obtained very
high oxytocin levels, along with different effect patterns,
compared to studies using RIA [33]. For example, some
studies that used ELISA have found no rise of oxytocin
levels during pregnancy [34]. In addition, the validity
and reliability of ELISA as a measure for oxytocin levels
have been seriously questioned [35].
The timing and frequency of collection of plasma
samples is also very important. Even with a specific and
sensitive technique for analysis of oxytocin, the short-
duration oxytocin pulses in labour require special
consideration. Repeated measurements during a limited
period of time (sampling at 30 s or 1 min intervals) will
allow detection of peaks [31].
The time period during which sampling is performed
is also of importance. For example, sampling at several
time points during pregnancy is obviously necessary to
detect a gestational rise. Likewise, the clear-cut rise of
maternal oxytocin levels in connection with birth can
only be identified if repeated samples are collected over
the duration of labour.
Discussion of the results
Oxytocin levels during labour and birth
There is no data suggesting that physiological labour on-
set occurs as a consequence of a sudden rise of oxytocin
levels. Several of the included studies, however, show a
gradual rise of oxytocin levels during physiological
labour. During the first stage of labour, oxytocin levels
are twice as high as before labour onset, as demon-
strated in Figs. 2 and 3a. The oxytocin pulses are very
short-lasting and may reach quite high concentrations
(Fig. 4). As labour progresses, these pulses increase in
size and frequency, reaching maximal frequency (3
pulses per 10 min) just before the baby is born (Table 4
and Figs. 2, and 4).
Some of the oxytocin peaks occurring during labour
may be spontaneous and of central origin, whereas some
of them are likely to be induced in response to activation
of the Ferguson reflex. This reflex is stimulated when
uterine contractions press the head of the foetus down
against the cervix and vaginal wall. Afferent sensory
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spinal cord to the SON and PVN, resulting in the release
of oxytocin into both the brain and circulation. This
causes a feed-forward effect that accelerates oxytocin re-
lease, known as the Ferguson reflex [36]. The maximal
expression of this reflex during birth corresponds to the
3- to 4-fold rise of oxytocin levels observed during, and
immediately after, birth of the baby (Table 4 and Fig. 2).
Link between oxytocin and uterine contractions
The uterine muscles are highly sensitive to oxytocin in
labour and birth due to upregulation of the sensitivity/
concentration of oxytocin receptors by high oestrogen
elevations in late pregnancy [37]. In addition, oxytocin
release in labour promotes prostaglandin release, further
strengthening uterine contractions and labour progress
[23, 37]. As little as 4–8 mU given as bolus dose
stimulated uterine contractions just before labour
onset [31].
It may seem surprising that studies consistently found
no temporal connection between uterine contractions
and oxytocin peaks, even when sampling was very fre-
quent. This may be explained by the involvement of the
autonomic nervous system (ANS) in labour, and espe-
cially the parasympathetic nervous system (PSNS)
branch. The uterus is innervated by both PSNS and SNS
branches of the ANS, with powerful effects on labour
and birth. Parasympathetic activation promotes uterine
contractility and increases circulation to the uterus and
baby. The role of the SNS is more complicated. Sympa-
thetic activation (e.g. from anxiety or fear) may trigger
ineffective contractions and inhibit uterine circulation,
or may in some cases give rise to long-lasting and more
painful contractions [38].
Oxytocin in the brain activates the PSNS. Some oxyto-
cinergic fibres from the PVN reach the parasympathetic
networks (plexa) in the lumbosacral region of the spinal
cord, where they connect with neurons that stimulate
uterine contractions [39]. Thus neurogenic oxytocin may
influence and amplify the effects of circulating oxytocin,
as the release of oxytocin into the circulation and the ac-
tivation of the PSNS from the PVN are coordinated.
This two-fold effect of oxytocin on uterine contrac-
tions, via circulating oxytocin and via the PSNS, may ex-
plain the unexpected finding that the peaks of oxytocin
seen during normal labour are not directly in time asso-
ciated with uterine contractions [16, 19–21].
Central actions of oxytocin during labour and birth
As discussed in the introduction, oxytocin induces many
positive effects by its central actions within the brain.
These include stimulation of friendly social interaction,
enhanced wellbeing and positive mood, and reduced
anxiety, pain and stress [4]. Some of these effects alsooccur during labour and birth as a consequence of oxy-
tocin released in the brain. Oxytocin is released from
dendrites and cell bodies of the magnocellular neurons
of the SON and PVN during physiological labour and
birth. In addition oxytocin is released from nerves from
the parvocellular neurons in the PVN. In this way oxyto-
cin reaches important regulatory areas in the brain, for
example areas involved in regulation of social behaviour
and fear, pain, stress and wellbeing. Obviously the cen-
tral effects of oxytocin are not induced by the oxytocin
released into circulation but directly from nerves within
the brain. In fact oxytocin in the circulation does not
pass into the brain because of the blood-brain barrier [4,
40–42].
Examples of central oxytocin effects during labour and
birth
Oxytocin released within the brain and the spinal cord
during labour and birth will decrease the experience of
pain. This effect involves release of endogenous opiates.
The oxytocin induced pain relief during birth may be
linked to the amnesic effect, which helps the new
mother forget the intensity of labour [43].
Women can experience strong positive emotions dur-
ing birth, especially after the baby is born [4, 44, 45]. As
shown in several of the included articles, plasma oxyto-
cin levels exhibit a 3–4-fold rise in the circulation as the
baby is born. Most likely a parallel rise of oxytocin also
occurs in the brain at this point of time, which might be
linked to a release of dopamine [4].
Oxytocin released during labour and birth promotes
the future interaction between mother and baby and de-
creases fear and stress levels. After birth, oxytocin helps
the mother to bond with her baby, and this effect is rein-
forced by skin-to-skin contact immediately after birth
[4]. In addition, central release of oxytocin in labour en-
hances sensitivity of the skin, which further facilitates
maternal oxytocin elevations during postpartum skin-to-
skin contact [46]. At this time, oxytocin also promotes
vasodilation of the mother’s chest wall for newborn
warming [47].
Given the information above, it is obvious that oxyto-
cin released in the brain during labour and birth exerts
many positive and adaptive effects in the mother. Not
only is the intensity of pain, fear and stress decreased,
but also the mother’s wellbeing is actively stimulated,
and future interactions and bonding with her baby are
facilitated [4, 41–47].
The central release of oxytocin, and its positive effects,
may be modified by environmental factors. Stressful and
unfamiliar situations and surroundings may increase
stress levels and decrease oxytocin release and PSNS ac-
tivity. Alternatively, situations perceived as safe, familiar,
friendly and supportive by the mother are likely to do
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activity. This will facilitate labour progress, as well as the
positive central actions caused by oxytocin.
These positive oxytocin effects also require the full
functioning of neural pathways involved in physiological
labour and birth. These pathways include the Ferguson
reflex, which can be effectively be blocked by medical in-
terventions such as epidural analgesia. In this way epi-
dural analgesia may not only reduce oxytocin blood
levels and progress of labour, but also central oxytocin
levels and adaptive effects [4, 21].
Levels and effects after infusion of synthetic oxytocin
While the use of synthetic oxytocin was not initially the
subject of this review, some of the included studies mea-
sured oxytocin levels when synthetic oxytocin was in-
fused. In view of the widespread use of synthetic
oxytocin for induction and augmentation of labour, we
decided to include this information.
Infusions of synthetic oxytocin for induction or aug-
mentation of labour are generally commenced at a low
rate of around 1–3 mU/min, with the dose either in-
creased step-wise (arithmetic) or doubled (geometric) at
15–40min intervals, although protocols vary widely.
Generally the maximum dose of synthetic oxytocin does
not exceed 32mU /min [23, 48].
One of the included studies found that, when synthetic
oxytocin was infused in doses up to 9 mU/min, maternal
plasma levels of oxytocin were similar to those observed
during physiological labour [23] whereas doses around
10–16mU/min gave rise to levels that were approxi-
mately double those of physiological labour (Fig. 3a & b)
[23]. This implies that the concentrations obtained fol-
lowing infusion rates over 16 mU/min exceeds physio-
logical levels. A steady state concentration was found by
40min after a change in infusion rate [24]. It is of inter-
est that administration of a bolus as low as 4–8 mU of
synthetic oxytocin gave rise to uterine contractions in
women at term, with an elevation of oxytocin levels
comparable to levels obtained during a physiological
pulse in labour [31].
In contrast to the episodic, narrow peaks of oxytocin
in physiological labour, administration of synthetic oxy-
tocin produced flat oxytocin levels in maternal blood.
These flat levels may influence the pattern of uterine
contractions and contribute to the hyperstimulation that
can result from high doses of synthetic oxytocin [48].
Excessive uterine activity may also compromise fetal
blood supply, causing hypoxia.
In addition, prolonged exposure to synthetic oxytocin
may eventually lead to reduced contractility of the uter-
ine muscles due to desensitization of oxytocin receptors
[49]. The decreased efficacy of oxytocin may also in-
crease the risk of postpartum haemorrhage [50]. Inaddition, the high levels of lactate that accumulate in
uterine muscle [51], and hypoxia due to excessive uter-
ine contractions, may also contribute to these risks.
The pharmacokinetics of oxytocin during labour are
surprisingly poorly studied. As studied in non-pregnant
women, synthetic oxytocin is degraded according to a
two-compartment model [52]. However in labour, the
levels of oxytocinases, the enzymes that degrade oxyto-
cin, increase 10- to 20-fold, which may also influence
the degradation of oxytocin and thereby the half-life and
metabolic clearance rate of oxytocin [19, 24, 53].
Implications for clinical use of synthetic oxytocin in
labour and birth
Following on from the findings of our systematic review,
an important question is: “How can the administration
of synthetic oxytocin in labour and birth imitate physio-
logical patterns and effects, as far as possible?”
From this perspective, a more physiological method of
administering synthetic oxytocin would be to use a pul-
satile infusion pattern, which is more aligned with labour
physiology. Several studies have found that the total dose
requirement of oxytocin is 20 to 60% reduced with pul-
satile administration compared to continuous infusions.
In addition, there is generally less hyperstimulation, and
equivalent outcomes for mothers and babies such as cae-
sarean rates and outcomes for the baby [54–61]. In
addition, a recent in vitro study has suggested that the
pulsatile administration pattern of oxytocin may main-
tain myometrial receptor sensitivity [62] and therfore
maintain uterine contractility.
Another possible conclusion from the recent pharma-
cokinetic data, which show a relatively longer half-life of
oxytocin than currently assumed [52], would be that
doses should not be increased with too short intervals.
Intervals of 30–40 min rather than 15min would be
consistent with these understandings. Too-short dosing
intervals could lead to unnecessarily high cumulative ex-
posures, as levels are increased before the full effects of
the previous doses are achieved. In order to achieve the
lowest dose exposure, it makes sense to carefully titrate
the dose against effect, taking into account this pharma-
cokinetic data. Arithmetical vs geometric dose increases
would be more consistent with low dose exposure.
These hypotheses and models need to be thoroughly
studied in relation to the use of synthetic oxytocin in
labour, especially given its widespread use.
Conclusions
This systematic review shows that plasma levels of oxy-
tocin increase gradually during pregnancy and through
physiological labour. Short-lasting peaks of oxytocin
occur with increasing frequency during labour, and a
substantial rise of oxytocin levels occurs when the baby
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tions. Infusions of synthetic oxytocin at low doses (less
than 10 mU/mín) give rise to similar levels of oxytocin
as during physiological labour. Oxytocin released into
the brain during labour and birth influences neuroendo-
crine mechanisms and thereby maternal mood, behav-
iour, and physiology in a positive way. Infusions of
synthetic oxytocin do not give rise to the same beneficial
effects in the brain as does endogenous oxytocin re-
leased during physiological labour and birth, because
oxytocin from the circulation does not pass the blood
brain barrier. This implies that labour with synthetic
oxytocin infusion does not fully replicate the adaptive ef-
fects of physiological labour and birth.
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